Janus Henderson Group PLC Exact Sciences Corp Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 15,500 shares of EXAS stock, worth $786,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,500

Previous 15,828 2.07%

Holding current value

$786,315

Previous $1.09 Million 40.16%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $13,556 - $24,357	-328 Reduced 2.07%	15,500 $654,000
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $112 - $147	2 Added 0.01%	15,828 $1.09 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $8,209 - $10,525	-139 Reduced 0.87%	15,826 $1.17 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $39,102 - $58,730	-593 Reduced 3.58%	15,965 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $102,669 - $155,691	-1,638 Reduced 9.0%	16,558 $1.55 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $62,149 - $93,204	-1,317 Reduced 6.75%	18,196 $1.23 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $12,018 - $21,047	396 Added 2.07%	19,513 $966,000
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $125,226 - $193,382	-3,917 Reduced 17.01%	19,117 $621,000
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $412,897 - $883,886	-11,595 Reduced 33.48%	23,034 $908,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $1.99 Million - $2.86 Million	34,629 New	34,629 $2.42 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $4.31 Million - $5.99 Million	-59,466 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$90.24 - $124.05 $161,890 - $222,545	-1,794 Reduced 2.93%	59,466 $5.68 Million
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $99,092 - $147,347	1,058 Added 1.76%	61,260 $7.61 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $3.14 Million - $4.18 Million	26,959 Added 81.1%	60,202 $7.93 Million
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $2.85 Million - $4.07 Million	-28,633 Reduced 46.27%	33,243 $4.41 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $29.1 Million - $40.7 Million	-399,386 Reduced 86.59%	61,876 $6.31 Million
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $4.23 Million - $7.04 Million	-75,875 Reduced 14.13%	461,262 $40.1 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $598,668 - $1.65 Million	15,796 Added 3.03%	537,137 $31.2 Million
Q4 2019 Feb 18, 2020	BUY	$77.66 - $99.74 $13.2 Million - $17 Million	170,576 Added 48.63%	521,341 $48.2 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $29.2 Million - $39.6 Million	323,477 Added 1185.42%	350,765 $31.7 Million
Q2 2019 Jul 31, 2019	BUY	$89.51 - $118.04 $1.98 Million - $2.61 Million	22,101 Added 426.08%	27,288 $3.22 Million
Q1 2019 Apr 30, 2019	BUY	$61.98 - $96.5 $321,490 - $500,545	5,187 New	5,187 $449,000
Q3 2018 Nov 09, 2018	SELL	$48.29 - $80.6 $241,450 - $403,000	-5,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$37.84 - $69.96 $189,200 - $349,799	5,000 New	5,000 $299,000

Others Institutions Holding EXAS

# of Institutions

665

Shares Held

166M

Call Options Held

2.61M

Put Options Held

1.31M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.98B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Exact Sciences Corp Transaction History